tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:0QCV Stock Latest News

Notable companies reporting before tomorrow’s open
The FlyNotable companies reporting before tomorrow’s open
26m ago
CL
CVX
AbbVie reports results from Phase 3 studies evaluating upadacitinib
PremiumThe Fly
AbbVie reports results from Phase 3 studies evaluating upadacitinib
1d ago
ABBV
ABBV Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ABBV Earnings this Week: How Will it Perform?
1d ago
ABBV
Avidity Biosciences downgraded to Neutral from Buy at Roth Capital
PremiumThe Fly
Avidity Biosciences downgraded to Neutral from Buy at Roth Capital
3d ago
LLY
MRK
AbbVie Hold Rating: Balancing Strong Performance with Emerging Challenges
PremiumRatings
AbbVie Hold Rating: Balancing Strong Performance with Emerging Challenges
6d ago
ABBV
AbbVie reports ‘positive’ results from Phase 3b/4 SELECT-SWITCH study
PremiumThe FlyAbbVie reports ‘positive’ results from Phase 3b/4 SELECT-SWITCH study
10d ago
ABBV
AbbVie price target raised to $242 from $227 at Guggenheim
Premium
The Fly
AbbVie price target raised to $242 from $227 at Guggenheim
10d ago
ABBV
AbbVie completes acquisition of Gilgamesh Pharmaceuticals’ bretisilocin
Premium
The Fly
AbbVie completes acquisition of Gilgamesh Pharmaceuticals’ bretisilocin
13d ago
ABBV
AbbVie price target raised to $250 from $236 at Raymond James
PremiumThe Fly
AbbVie price target raised to $250 from $236 at Raymond James
13d ago
ABBV
Psychedelic: Needham initiates coverage of atai, GH Research, MindMed
PremiumThe Fly
Psychedelic: Needham initiates coverage of atai, GH Research, MindMed
14d ago
ABBV
ATAI
Enveric hires firm to contest post-grant review petition filed by Gilgamesh
PremiumThe Fly
Enveric hires firm to contest post-grant review petition filed by Gilgamesh
15d ago
ABBV
ENVB
AbbVie downgraded to Hold from Buy at Erste Group
PremiumThe Fly
AbbVie downgraded to Hold from Buy at Erste Group
17d ago
ABBV
AbbVie price target raised to $240 from $205 at Citi
PremiumThe FlyAbbVie price target raised to $240 from $205 at Citi
17d ago
ABBV
AbbVie announces FDA approval of updated indication statement for RINVOQ
Premium
The Fly
AbbVie announces FDA approval of updated indication statement for RINVOQ
17d ago
ABBV
AbbVie to present new data from ADC platform at ESMO
Premium
The Fly
AbbVie to present new data from ADC platform at ESMO
17d ago
ABBV
AbbVie price target raised to $284 from $231 at Piper Sandler
PremiumThe Fly
AbbVie price target raised to $284 from $231 at Piper Sandler
20d ago
ABBV
Needham medtech & diagnostics analysts hold analyst/industry conference call
PremiumThe Fly
Needham medtech & diagnostics analysts hold analyst/industry conference call
21d ago
ABBV
APYX
AbbVie price target raised to $250 from $245 at Cantor Fitzgerald
PremiumThe Fly
AbbVie price target raised to $250 from $245 at Cantor Fitzgerald
21d ago
ABBV
Aldeyra price target raised to $7 from $6 at Jefferies
PremiumThe Fly
Aldeyra price target raised to $7 from $6 at Jefferies
22d ago
ABBV
ALDX
AbbVie reports ‘positive’ results from Phase 2 ELATE trial
PremiumThe FlyAbbVie reports ‘positive’ results from Phase 2 ELATE trial
24d ago
ABBV
Wells says Biktarvy patent settlement ‘big deal’ for Gilead at, $6-$12 upside
Premium
The Fly
Wells says Biktarvy patent settlement ‘big deal’ for Gilead at, $6-$12 upside
24d ago
ABBV
GILD
AbbVie sees FY25 adjusted EPS $10.38-$10.58 with IPR&D, milestones expense
Premium
The Fly
AbbVie sees FY25 adjusted EPS $10.38-$10.58 with IPR&D, milestones expense
27d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >